Washington Capital Management’s Edwards Lifesciences EW Stock Holding History

Washington Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,200	Closed	-$560K	–	96
2019 Q4	$560K	Sell	7,200 -2,400	-25%	-$187K	0.48%	49
2019 Q3	$704K	Hold	9,600	–	–	0.69%	34
2019 Q2	$591K	Hold	9,600	–	–	0.67%	38
2019 Q1	$612K	Hold	9,600	–	–	0.69%	37
2018 Q4	$490K	Hold	9,600	–	–	0.57%	46
2018 Q3	$557K	Hold	9,600	–	–	0.53%	49
2018 Q2	$466K	Hold	9,600	–	–	0.48%	64
2018 Q1	$446K	Hold	9,600	–	–	0.45%	63
2017 Q4	$361K	Sell	9,600 -2,400	-20%	-$88.1K	0.36%	83
2017 Q3	$437K	Sell	12,000 -4,029	-25%	-$154K	0.46%	63
2017 Q2	$632K	Hold	16,029	–	–	0.71%	31
2017 Q1	$503K	Hold	16,029	–	–	0.58%	41
2016 Q4	$501K	Buy	16,029 +2,178	+16%	+$70.6K	0.62%	35
2016 Q3	$557K	Hold	13,851	–	–	0.77%	27
2016 Q2	$460K	Sell	13,851 -61,311	-82%	-$2.1M	0.65%	37
2016 Q1	$2.21M	Sell	75,162 -16,344	-18%	-$451K	1.62%	12
2015 Q4	$2.41M	Sell	91,506 -654	-0.7%	-$17K	1.5%	12
2015 Q3	$2.18M	Buy	92,160 +2,934	+3%	+$70.8K	1.37%	18
2015 Q2	$2.12M	Hold	89,226	–	–	1.19%	26
2015 Q1	$2.12M	Sell	89,226 -59,862	-40%	-$1.34M	1.22%	23
2014 Q4	$3.17M	Hold	149,088	–	–	1.32%	11
2014 Q3	$2.54M	Buy	149,088 +24,078	+19%	+$380K	1%	37
2014 Q2	$1.79M	Sell	125,010 -28,998	-19%	-$393K	0.66%	87
2014 Q1	$1.9M	Sell	154,008 -3,678	-2%	-$42.4K	0.69%	80
2013 Q4	$1.73M	Buy	157,686 +6,966	+5%	+$78.5K	0.42%	112
2013 Q3	$1.75M	Sell	150,720 -7,002	-4%	-$81.9K	0.46%	99
2013 Q2	$1.77M	Buy	+157,722	New	+$1.87M	0.46%	98

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Washington Capital Management's EW Position: Q1 2020 in Review

Washington Capital Management sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 7,200 shares — an estimated $560K sold.

Washington Capital Management first reported a position in EW in Q2 2013 and held it in 27 quarters. The position peaked at $3.17M in Q4 2014. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

Washington Capital Management reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
Washington Capital Management sold 7,200 Edwards Lifesciences shares in Q1 2020, an estimated $560K.
Washington Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 27 quarters.
Washington Capital Management's Edwards Lifesciences position peaked at $3.17M in Q4 2014.
1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Washington Capital Management's 13F filing for Q1 2020, filed 6 May 2020.